96 related articles for article (PubMed ID: 1820013)
1. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis.
Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T
Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
[TBL] [Abstract][Full Text] [Related]
3. A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis.
Hirano T; Manabe T
J Int Med Res; 1992 Jun; 20(3):211-7. PubMed ID: 1383065
[TBL] [Abstract][Full Text] [Related]
4. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
Hirano T; Manabe T; Tobe T
Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836
[TBL] [Abstract][Full Text] [Related]
5. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis.
Hirano T; Manabe T; Tobe T
Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294
[TBL] [Abstract][Full Text] [Related]
6. Effect of prostaglandin E2 on cellular, lysosomal and mitochondrial fragility in caerulein-induced pancreatitis in rats.
Manabe T; Hirano T; Ando K; Yotsumoto F; Tobe T
Hepatogastroenterology; 1993 Oct; 40(5):463-6. PubMed ID: 8270235
[TBL] [Abstract][Full Text] [Related]
7. [Changes of parotid gland in rat caerulein-induced acute pancreatitis: study on in vitro system].
Hirano T; Manabe T; Tobe T
Nihon Geka Hokan; 1990 Jul; 59(4):310-4. PubMed ID: 1718233
[TBL] [Abstract][Full Text] [Related]
8. Effect of short-term pancreatico-biliary duct obstruction with intraductal hypertension on subcellular organelle fragility and pancreatic adenylate energy metabolism in rats: protective effect of a new protease inhibitor, E-3123.
Hirano T; Manabe T
Acta Chir Belg; 1994; 94(2):80-5. PubMed ID: 7517090
[TBL] [Abstract][Full Text] [Related]
9. Effect of prostaglandin E on the redistribution of lysosomal enzymes in caerulein-induced pancreatitis.
Hirano T; Manabe T; Yotsumoto F; Ando K; Imanishi K; Tobe T
Hepatogastroenterology; 1993 Apr; 40(2):155-8. PubMed ID: 7685311
[TBL] [Abstract][Full Text] [Related]
10. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate].
Hirano T; Manabe T; Tobe T
Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776
[TBL] [Abstract][Full Text] [Related]
11. [Changes of lysosomal and digestive enzymes in rat caerulein pancreatitis].
Hirano T; Manabe T; Imanishi K; Tobe T
Nihon Geka Hokan; 1991 Mar; 60(2):122-34. PubMed ID: 1726396
[TBL] [Abstract][Full Text] [Related]
12. Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats: protective effect of a potent new protease inhibitor, E-3123.
Hirano T; Manabe T; Yotsumoto F; Ohshio G; Nio Y
Nihon Geka Hokan; 1992 May; 61(3):234-48. PubMed ID: 1280076
[TBL] [Abstract][Full Text] [Related]
13. [Changes of acinar cells in the pancreato-biliary duct ligation with exocrine pancreatic stimulation model in rats; protective effects of a new potent protease inhibitor, ONO3307].
Hirano T; Yotsumoto TM; Ando K; Tobe T
Nihon Geka Hokan; 1991 Sep; 60(5):342-53. PubMed ID: 1726453
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypothermia on pancreatic acinar cells in rats.
Hirano T; Manabe T; Calne R; Printz H
Nihon Geka Hokan; 1992 Jul; 61(4):320-33. PubMed ID: 1281973
[TBL] [Abstract][Full Text] [Related]
15. E-3123, a new synthetic protease inhibitor, protects against deoxycholic acid-induced acute pancreatitis in dogs.
Iwatsuki K; Horiuchi A; Yonekura H; Ren LM; Chiba S
Arch Int Pharmacodyn Ther; 1990; 308():168-77. PubMed ID: 1711836
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats.
Hirano T; Manabe T; Steer M; Printz H; Calne R; Tobe T
Surg Gynecol Obstet; 1993 Apr; 176(4):371-81. PubMed ID: 8460415
[TBL] [Abstract][Full Text] [Related]
17. "Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis.
Hirano T; Manabe T
Nihon Geka Hokan; 1992 Nov; 61(6):433-44. PubMed ID: 1306981
[TBL] [Abstract][Full Text] [Related]
18. Cause-effect relationships between zymogen activation and other early events in secretagogue-induced acute pancreatitis.
Van Acker GJ; Weiss E; Steer ML; Perides G
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1738-46. PubMed ID: 17332471
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of gabexate mesilate (FOY) against impaired pancreatic energy metabolism in rat acute pancreatitis induced by caerulein.
Hirano T; Manabe T; Tobe T
Life Sci; 1991; 49(22):PL179-84. PubMed ID: 1719326
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis.
Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T
Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
